Markets

News Details

( 24 Jul 2020)
Cipla - Press Release

Cipla Limited has informed the Exchange regarding a press release dated July 24, 2020, titled "Press Release Cipla receives regulatory approval for launch of Ciplenza (Favipiravir 200 mg) in India to treat mild to moderate COVID-19".